Skip to main content

Oncologists Accepting Humana in Boston, MA

93 verified oncologists in Boston, Massachusetts accept Humana. Profiles cover focus areas including Genitourinary Oncology, Medical Oncology, and Head & Neck Oncology. Common hospital affiliations include Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Massachusetts General Hospital.

Ursula Matulonis

Ursula Matulonis, MD

Professor of Medicine, Harvard Medical School; Chief and Director, Division of Gynecologic Oncology, Dana-Farber Cancer Institute

Oncology

Boston, MA30+ years
Genitourinary OncologyMedical Oncology
Robert Haddad

Robert Haddad, MD

Chief, Division of Head and Neck Oncology; McGraw Chair in Head and Neck Oncology; Professor of Medicine, Harvard Medical School

Oncology

Boston, MA30+ years
Head & Neck OncologyMedical Oncology
Patrick Ott

Patrick Ott, MD

Professor of Medicine, Harvard Medical School; Clinical Director, Melanoma Disease Center; Director, Clinical Sciences, Center for Immuno-Oncology; Senior Physician

Oncology

Boston, MA30+ years
Melanoma & Cutaneous OncologyMedical Oncology
Kenneth Anderson

Kenneth Anderson, MD

Kraft Family Professor of Medicine, Harvard Medical School; Director, LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute

Oncology

Boston, MA30+ years
Hematology & OncologyMedical Oncology
Vincent Ho

Vincent Ho, MD

Professor of Medicine, Harvard Medical School; Director of Clinical Operations, Stem Cell Transplantation, Dana-Farber Cancer Institute

Oncology

Boston, MA30+ years
Medical OncologyHematology & Oncology
Susana Campos

Susana Campos, MD MPH

Assistant Professor, Medicine, Brigham and Women's Hospital, Harvard Medical School

Oncology

Boston, MA30+ years
GI OncologyMedical Oncology
Suzanne George

Suzanne George, MD

Chief, Division of Sarcoma; Clinical Research Director, Sarcoma Center; Associate Professor of Medicine, Harvard Medical School

Oncology

Boston, MA30+ years
SarcomaMedical Oncology
Joseph Antin

Joseph Antin, MD

Chairman of the Steering Committee of the BMT Clinical Trial Network.; Chief, Stem Cell Transplantation, Emeritus

Oncology

Boston, MA30+ years
Medical Oncology
Jennifer Chan

Jennifer Chan, MD

Associate Professor of Medicine, Harvard Medical School; Clinical Director, Gastrointestinal Cancer Center; Director, Program in Carcinoid and Neuroendocrine Tumors, Dana-Farber Cancer Institute

Oncology

Boston, MA20+ years
GI OncologyMedical Oncology
Robert Soiffer

Robert Soiffer, MD

Chief of the Division of Hematologic Malignancies; Codirector of the Adult Stem Cell Transplantation Program; Worthington and Margaret Collette Professor of Medicine in the Field of Hematologic Oncology, Harvard Medical School

Oncology

Boston, MA30+ years
Hematology & OncologyMedical Oncology
Harold Burstein

Harold Burstein, MD PHD

Director of Academic Partnerships; Director of Breast Cancer Education

Oncology

Boston, MA30+ years
Medical Oncology
Howard Kaufman

Howard Kaufman, M.D.

Professor, Surgery

Oncology

Boston, MA30+ years
Surgical Oncology
Arnold Freedman

Arnold Freedman, MD

Professor of Medicine at Harvard Medical School, a member of Dana-Farber Cancer Institute's Department of Medical Oncology, and an attending physician at Brigh; Professor of Medicine, Harvard Medical School

Oncology

Boston, MA30+ years
Medical Oncology
Erica Mayer

Erica Mayer, MD MPH

Assistant Professor, Medicine, Brigham and Women's Hospital, Harvard Medical School; Director, Breast Cancer Clinical Research, Dana-Farber Breast Oncology Program

Oncology

Boston, MA20+ years
Breast OncologyMedical Oncology
Jennifer Ligibel

Jennifer Ligibel, MD

Professor at Harvard Medical School and a Senior Physician in the Breast Oncology Center at the Dana-Farber Cancer Institute. Dr. Ligibel’s research focuses on; Director of the Leonard P. Zakim Center for Integrative Therapies and Healthy Living and has built a comprehensive clinical Healthy Living Program for patient

Oncology

Boston, MA30+ years
Medical Oncology
Bruce Johnson

Bruce Johnson, MD

Professor Emeritus of Medicine, Harvard Medical School; Institute Physician, Dana-Farber Cancer Institute

Oncology

Boston, MA30+ years
Thoracic OncologyMedical Oncology
Ann Partridge

Ann Partridge, MD MPH

Chief Clinical Strategy Officer, Vice Chair of Medical Oncology, and founder and director of Young and Strong, the Program for Young Adults with Breast Can; Chair in Breast Cancer Research at Dana-Farber. She conducts clinical research focused on improving cancer care and outcomes with a particular focus on you

Oncology

Boston, MA30+ years
Medical Oncology
Elizabeth Buchbinder

Elizabeth Buchbinder, M.D.

Assistant Professor of Medicine, Harvard Medical School

Oncology

Boston, MA20+ years
Melanoma & Cutaneous OncologyMedical Oncology
Jiping Wang

Jiping Wang, MD, PHD

Surgical Oncologist, Associate Professor of Surgery, Harvard Medical School

Oncology

Boston, MA30+ years
Surgical Oncology
Filipa Lynce

Filipa Lynce, M.D.

Assistant Professor of Medicine, Harvard Medical School; Associate Director, Inflammatory Breast Cancer Program, Dana-Farber Cancer Institute

Oncology

Boston, MA20+ years
Breast OncologyMedical Oncology

Frequently Asked Questions

How do I know these oncologists accept Humana?
Each profile on this page lists Humana among its accepted health plans. Plan participation can change — confirm directly with the practice before your visit.
What Humana plans do these oncologists accept?
Plan-level detail (PPO, HMO, EPO, Medicare Advantage, etc.) varies by specialists. Open a specific provider profile to see the exact Humana plans they've published as accepted.
What should I look for when picking a oncologist that takes Humana?
Start with clinical fit. Profiles on this page mention focus areas including Genitourinary Oncology, Medical Oncology, and Head & Neck Oncology. Then verify the specific Humana plan you carry, compare credentials and affiliations, and check whether the profile mentions accepting new patients.
Are these oncologists accepting new patients?
Profile detail on availability varies. Open a specific profile to see what each provider has published about new-patient access and typical wait times.